Download PDF
CC BY 4.0 · Endoscopy 2023; 55(06): 491-498
DOI: 10.1055/a-2015-8883
Original article

The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett’s esophagus

Mathew Vithayathil
1   Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
2   Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom
,
Ines Modolell
3   Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
,
Jacobo Ortiz-Fernandez-Sordo
4   Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom
,
Apostolos Pappas
1   Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
,
Wladyslaw Januszewicz
1   Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
5   Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Centre for Postgraduate Education, Warsaw, Poland
,
Maria O’Donovan
6   Department of Histopathology, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
,
Michele Bianchi
1   Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
,
Jonathan R. White
4   Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom
,
Philip Kaye
7   Department of Histopathology, Nottingham University Hospital NHS Foundation Trust, Nottingham, United Kingdom
,
Krish Ragunath
4   Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom
,
Massimiliano di Pietro
1   Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
3   Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
› Author AffiliationsSupported by: Cambridge Cancer Research Funds Charity
Supported by: Experimental Cancer Medicine Centre A0427637
Supported by: Cancer Research UK Pump Priming Research Grant A25117
Supported by: NIHR Cambridge Biomedical Research Centre BRC-1215–20014
› Further Information
Also available at
   Permissions and Reprints


Referred to by:

Author commentary on Mathew Vithayathil et al.Endoscopy 2023; 55(06): v15-v15
DOI: 10.1055/a-2001-3918

Referred to by:

High quality Barrett’s endoscopy: inspection time is a critical componentEndoscopy 2023; 55(06): 499-500
DOI: 10.1055/a-2042-9837

Abstract

Background Endoscopic surveillance of Barrett’s esophagus (BE) with Seattle protocol biopsies is time-consuming and inadequately performed in routine practice. There is no recommended procedural time for BE surveillance. We investigated the duration of surveillance procedures with adequate tissue sampling and effect on dysplasia detection rate (DDR).

Methods We performed post hoc analysis from the standard arm of a crossover randomized controlled trial recruiting patients with BE (≥C2 and/or ≥M3) and no clearly visible dysplastic lesions. After inspection with white-light imaging, targeted biopsies of subtle lesions and Seattle protocol biopsies were performed. Procedure duration and biopsy number were stratified by BE length. The effect of endoscopy-related variables on DDR was assessed by multivariable logistic regression.

Results Of 142 patients recruited, 15 (10.6 %) had high grade dysplasia/intramucosal cancer and 15 (10.6 %) had low grade dysplasia. The median procedural time was 16.5 minutes (interquartile range 14.0–19.0). Endoscopy duration increased by 0.9 minutes for each additional 1 cm of BE length. Seattle protocol biopsies had higher sensitivity for dysplasia than targeted biopsies (86.7 % vs. 60.0 %; P = 0.045). Longer procedural time was associated with increased likelihood of dysplasia detection on quadrantic biopsies (odds ratio [OR] 1.10, 95 %CI 1.00–1.20, P = 0.04), and for patients with BE > 6 cm also on targeted biopsies (OR 1.21, 95 %CI 1.04–1.40; P = 0.01).

Conclusions In BE patients with no clearly visible dysplastic lesions, longer procedural time was associated with increased likelihood of dysplasia detection. Adequate time slots are required to perform good-quality surveillance and maximize dysplasia detection.

Tables 1 s–4 s, Fig. 1 s



Publication History

Received: 22 May 2022

Accepted after revision: 23 November 2022

Accepted Manuscript online:
19 January 2023

Article published online:
09 March 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Desai TK, Krishnan K, Samala N. et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut 2012; 61: 970-976
    CrossrefPubMedSearch in Google Scholar
  • 2 Fitzgerald RC, di Pietro M, Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63: 7-42
    CrossrefPubMedSearch in Google Scholar
  • 3 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Shaheen NJ, Falk GW, Iyer PG. et al. Diagnosis and management of Barrett’s esophagus: an updated ACG Guideline. Am J Gastroenterol 2022; 117: 559-587
    Search in Google Scholar
  • 5 Cooper GS, Yuan Z, Chak A. et al. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer 2002; 95: 32-38
    CrossrefPubMedSearch in Google Scholar
  • 6 El-Serag HB, Naik AD, Duan Z. et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut 2016; 65: 1252-1260
    CrossrefPubMedSearch in Google Scholar
  • 7 Verbeek RE, Leenders M, Ten Kate FJW. et al. Surveillance of Barrett’s esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Am J Gastroenterol 2014; 109: 1215-1222
    CrossrefPubMedSearch in Google Scholar
  • 8 Corley DA, Mehtani K, Quesenberry C. et al. Impact of endoscopic surveillance on mortality from Barrett’s esophagus-associated esophageal adenocarcinomas. Gastroenterology 2013; 145: 312-319
    CrossrefPubMedSearch in Google Scholar
  • 9 Levine DS, Haggitt RC, Blount PL. et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 1993; 105: 40-50
    CrossrefPubMedSearch in Google Scholar
  • 10 Sharma P, Hawes RH, Bansal A. et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut 2013; 62: 15-21
    CrossrefPubMedSearch in Google Scholar
  • 11 Longcroft-Wheaton G, Fogg C, Chedgy F. et al. A feasibility trial of acetic acid-targeted biopsies versus nontargeted quadrantic biopsies during Barrett’s surveillance: the ABBA trial. Endoscopy 2020; 52: 29-36
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Gupta N, Gaddam S, Wani SB. et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc 2012; 76: 531-538
    CrossrefPubMedSearch in Google Scholar
  • 13 Abrams JA, Kapel RC, Lindberg GM. et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009; 7: 736-742
    CrossrefPubMedSearch in Google Scholar
  • 14 Roumans CAM, van der Bogt RD, Steyerberg EW. et al. Adherence to recommendations of Barrett’s esophagus surveillance guidelines: a systematic review and meta-analysis. Endoscopy 2020; 52: 17-28
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Vithayathil M, Modolell I, Ortiz-Fernandez-Sordo J. et al. Image-enhanced endoscopy and molecular biomarkers vs Seattle protocol to diagnose dysplasia in Barrett’s esophagus. Clin Gastroenterol Hepatol 2022; 20: 2514-2523
    CrossrefPubMedSearch in Google Scholar
  • 16 Sharma P, Dent J, Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
    CrossrefPubMedSearch in Google Scholar
  • 17 Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-131
    Search in Google Scholar
  • 18 Cameron GR, Jayasekera CS, Williams R. et al. Detection and staging of esophageal cancers within Barrett’s esophagus is improved by assessment in specialized Barrett’s units. Gastrointest Endosc 2014; 80: 971-983
    CrossrefPubMedSearch in Google Scholar
  • 19 Schölvinck DW, van der Meulen K, Bergman JJGHM. et al. Detection of lesions in dysplastic Barrett’s esophagus by community and expert endoscopists. Endoscopy 2017; 49: 113-120
    PubMedSearch in Google Scholar
  • 20 Nguyen TH, Thrift AP, George R. et al. Prevalence and predictors of missed dysplasia on index Barrett’s esophagus diagnosing endoscopy in a veteran population. Clin Gastroenterol Hepatol 2022; 20: e876-e889
    CrossrefPubMedSearch in Google Scholar
  • 21 Vajravelu RK, Kolb JM, Thanawala SU. et al. Characterization of prevalent, post-endoscopy, and incident esophageal cancer in the United States: a large retrospective cohort study. Clin Gastroenterol Hepatol 2022; 20: 1739-1747
    CrossrefPubMedSearch in Google Scholar
  • 22 Desai M, Lieberman D, Srinivasan S. et al. Post-endoscopy Barrett’s neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy. Endoscopy 2022; 54: 881-889
    Thieme ConnectPubMedSearch in Google Scholar
  • 23 Bisschops R, Areia M, Coron E. et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016; 48: 843-864
    Search in Google Scholar
  • 24 Beg S, Ragunath K, Wyman A. et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 2017; 66: 1886-1899
    CrossrefPubMedSearch in Google Scholar
  • 25 Sharma P, Meining AR, Coron E. et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011; 74: 465-472
    CrossrefPubMedSearch in Google Scholar